tiprankstipranks
Trending News
More News >
Sangui BioTech International (DE:SBH)
:SBH
Germany Market

Sangui BioTech International (SBH) Income Statement

Compare
0 Followers

Sangui BioTech International Income Statement

Last quarter (Q3 2023), Sangui BioTech International's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Sangui BioTech International's net income was $-38.19K. See Sangui BioTech International’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 69.19K$ 65.58K$ 28.91K$ 88.00K$ 77.09K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 770.00$ 816.00$ 1.21K$ ―$ ―
EBITDA
$ -22.48K$ -165.24K$ -183.22K$ -330.83K$ -207.50K
Operating Income
$ -139.45K$ -151.14K$ -181.39K$ -337.63K$ -208.04K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -59.31K$ -198.89K$ -192.74K$ -703.97K$ -445.60K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Sangui BioTech International Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis